Literature DB >> 16442618

Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function.

George D Dalton1, William L Dewey.   

Abstract

Signal transduction cascades involving cAMP-dependent protein kinase are highly conserved among a wide variety of organisms. Given the universal nature of this enzyme it is not surprising that cAMP-dependent protein kinase plays a critical role in numerous cellular processes. This is particularly evident in the nervous system where cAMP-dependent protein kinase is involved in neurotransmitter release, gene transcription, and synaptic plasticity. Protein kinase inhibitor peptide (PKI) is an endogenous thermostable peptide that modulates cAMP-dependent protein kinase function. PKI contains two distinct functional domains within its amino acid sequence that allow it to: (1) potently and specifically inhibit the activity of the free catalytic subunit of cAMP-dependent protein kinase and (2) export the free catalytic subunit of cAMP-dependent protein kinase from the nucleus. Three distinct PKI isoforms (PKIalpha, PKIbeta, PKIgamma) have been identified and each isoform is expressed in the brain. PKI modulates neuronal synaptic activity, while PKI also is involved in morphogenesis and symmetrical left-right axis formation. In addition, PKI also plays a role in regulating gene expression induced by cAMP-dependent protein kinase. Future studies should identify novel physiological functions for endogenous PKI both in the nervous system and throughout the body. Most interesting will be the determination whether functional differences exist between individual PKI isoforms which is an intriguing possibility since these isoforms exhibit: (1) cell-type specific tissue expression patterns, (2) different potencies for the inhibition of cAMP-dependent protein kinase activity, and (3) expression patterns that are hormonally, developmentally and cell-cycle regulated. Finally, synthetic peptide analogs of endogenous PKI will continue to be invaluable tools that are used to elucidate the role of cAMP-dependent protein kinase in a variety of cellular processes throughout the nervous system and the rest of the body.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442618     DOI: 10.1016/j.npep.2005.10.002

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  59 in total

1.  Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes.

Authors:  Peter Pediaditakis; Jae-Sung Kim; Lihua He; Xun Zhang; Lee M Graves; John J Lemasters
Journal:  Biochem J       Date:  2010-11-01       Impact factor: 3.857

2.  A model for sealing plasmalemmal damage in neurons and other eukaryotic cells.

Authors:  Christopher S Spaeth; Elaine A Boydston; Lauren R Figard; Aleksej Zuzek; George D Bittner
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

3.  Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation.

Authors:  Patrick Kelly; Candice L Bailey; Patrick T Fueger; Christopher B Newgard; Patrick J Casey; Michelle E Kimple
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

4.  Dynamically committed, uncommitted, and quenched states encoded in protein kinase A revealed by NMR spectroscopy.

Authors:  Larry R Masterson; Lei Shi; Emily Metcalfe; Jiali Gao; Susan S Taylor; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-06       Impact factor: 11.205

5.  Separate intramolecular targets for protein kinase A control N-methyl-D-aspartate receptor gating and Ca2+ permeability.

Authors:  Teresa K Aman; Bruce A Maki; Thomas J Ruffino; Eileen M Kasperek; Gabriela K Popescu
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

6.  Transcriptional regulatory events initiated by Ascl1 and Neurog2 during neuronal differentiation of P19 embryonic carcinoma cells.

Authors:  Holly S Huang; Tanya M Redmond; Ginger M Kubish; Shweta Gupta; Robert C Thompson; David L Turner; Michael D Uhler
Journal:  J Mol Neurosci       Date:  2014-09-06       Impact factor: 3.444

7.  Selective disruption of the AKAP signaling complexes.

Authors:  Eileen J Kennedy; John D Scott
Journal:  Methods Mol Biol       Date:  2015

8.  Binding mechanism and dynamic conformational change of C subunit of PKA with different pathways.

Authors:  Wen-Ting Chu; Xiakun Chu; Jin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-30       Impact factor: 11.205

9.  PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.

Authors:  Ken Dabanaka; Suyoun Chung; Hidewaki Nakagawa; Yusuke Nakamura; Takehiro Okabayashi; Takeki Sugimoto; Kazuhiro Hanazaki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

10.  The cAMP-dependent protein kinase inhibitor H-89 attenuates the bioluminescence signal produced by Renilla Luciferase.

Authors:  Katie J Herbst; Michael D Allen; Jin Zhang
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.